Business Description
BioLife Solutions Inc
NAICS : 339113
SIC : 3841
ISIN : US09062W2044
Description
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.21 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.94 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 5.07 | |||||
| Beneish M-Score | -3.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23 | |||||
| 3-Year EPS without NRI Growth Rate | -118.2 | |||||
| 3-Year Book Growth Rate | 6.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 2.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.71 | |||||
| 9-Day RSI | 51.04 | |||||
| 14-Day RSI | 48.71 | |||||
| 6-1 Month Momentum % | 82.55 | |||||
| 12-1 Month Momentum % | -5.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.86 | |||||
| Quick Ratio | 1.83 | |||||
| Cash Ratio | 1.23 | |||||
| Days Inventory | 152.94 | |||||
| Days Sales Outstanding | 68.46 | |||||
| Days Payable | 45.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11 | |||||
| Shareholder Yield % | -1.16 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.63 | |||||
| Operating Margin % | -40.16 | |||||
| Net Margin % | -46.36 | |||||
| FCF Margin % | -13.18 | |||||
| ROE % | -19.04 | |||||
| ROA % | -15.42 | |||||
| ROIC % | -16.14 | |||||
| ROC (Joel Greenblatt) % | -75.95 | |||||
| ROCE % | -14.85 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.12 | |||||
| PB Ratio | 2.24 | |||||
| Price-to-Tangible-Book | 8.26 | |||||
| EV-to-EBIT | -13.06 | |||||
| EV-to-EBITDA | -16.6 | |||||
| EV-to-Revenue | 5.24 | |||||
| EV-to-Forward-Revenue | 7.36 | |||||
| EV-to-FCF | -39.79 | |||||
| Price-to-Projected-FCF | 4.61 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Net-Current-Asset-Value | 16.61 | |||||
| Earnings Yield (Greenblatt) % | -7.66 | |||||
| FCF Yield % | -2.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BLFS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioLife Solutions Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 143.272 | ||
| EPS (TTM) ($) | -1.52 | ||
| Beta | 2.09 | ||
| Volatility % | 74.25 | ||
| 14-Day RSI | 48.71 | ||
| 14-Day ATR ($) | 0.987826 | ||
| 20-Day SMA ($) | 17.152 | ||
| 12-1 Month Momentum % | -5.58 | ||
| 52-Week Range ($) | 8.9201 - 24.5 | ||
| Shares Outstanding (Mil) | 45.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioLife Solutions Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioLife Solutions Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioLife Solutions Inc Frequently Asked Questions
What is BioLife Solutions Inc(BLFS)'s stock price today?
The current price of BLFS is $16.78. The 52 week high of BLFS is $24.50 and 52 week low is $8.92.
When is next earnings date of BioLife Solutions Inc(BLFS)?
The next earnings date of BioLife Solutions Inc(BLFS) is 2024-05-10 Est..
Does BioLife Solutions Inc(BLFS) pay dividends? If so, how much?
BioLife Solutions Inc(BLFS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers